Researchers implemented daily chlorhexidine bathing for 16 months in a medical ICU with MRSA endemicity after a 14 month control period. They used regression analysis to find the affect of the bathing on MRSA acquisition, and they also measured MRSA chlorhexidine susceptibility with polymerase chain reaction tests.
They found a significant reduction in the incidence density of MRSA in the ICU.
“Daily chlorhexidine bathing resulted in a significantly decreasing trend of MRSA acquisition rates irrespective of increased MRSA prevalence rates in the medical ICU,” the study concludes. “There was no shift of chlorhexidine-resistant MRSA strains.”
More articles on chlorhexidine:
The growing body of evidence supporting CHG bathing
3 recent stories, studies on chlorhexidine
Triclosan or chlorhexidine: Which better prevents bacteria recolonization?
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.